The Cost of Personalized Medicine

Jayson Slotnik, JD, MPH

Video Categories: Pricing

Jayson Slotnik discusses the cost structure of diagnostics and pharmaceuticals in personalized medicine
March 31, 2015

Reality of the ASPIRE Study

Ajai Chari, MD, at the Mount Sinai School of Medicine in New York, deliberates on the results of the ASPIRE study as the most important thing to come out of ASH for the myeloma community. He mentions that although the study has very positive indications, the therapy isn’t really appropriate [ Read More ]

January 16, 2019

Overcoming Challenges to Molecular Biomarker Testing

Drs. Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges in biomarker testing—tissue stewardship and complexity of biomarker tests and results—and ways to overcome these challenges—improved communication among all members of the cancer care team and simplification of biomarker test results to focus on actionable biomarkers.